KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $202.0 million.

  • Abbott Laboratories' Change in Receivables rose 25438.6% to $202.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 12193.55%. This contributed to the annual value of $691.0 million for FY2024, which is 9410.11% up from last year.
  • Abbott Laboratories' Change in Receivables amounted to $202.0 million in Q3 2025, which was up 25438.6% from $410.0 million recorded in Q2 2025.
  • Abbott Laboratories' Change in Receivables' 5-year high stood at $751.0 million during Q1 2022, with a 5-year trough of -$530.0 million in Q3 2022.
  • Moreover, its 5-year median value for Change in Receivables was $188.0 million (2022), whereas its average is $124.8 million.
  • Within the past 5 years, the most significant YoY rise in Abbott Laboratories' Change in Receivables was 63714.29% (2022), while the steepest drop was 28042.33% (2022).
  • Abbott Laboratories' Change in Receivables (Quarter) stood at $189.0 million in 2021, then tumbled by 280.42% to -$341.0 million in 2022, then surged by 80.06% to -$68.0 million in 2023, then surged by 332.35% to $158.0 million in 2024, then grew by 27.85% to $202.0 million in 2025.
  • Its Change in Receivables was $202.0 million in Q3 2025, compared to $410.0 million in Q2 2025 and $262.0 million in Q1 2025.